Novel macromolecule CPD4 suppresses cell proliferation and metastasis of triple-negative breast cancer by targeting ROR1 protein
- 23 April 2025
- journal article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 310 (Pt 3) , 143301
Abstract
No abstract availableKeywords
Funding Information
- Indian Council of Medical Research (33/10/2019-TF/Rare/BMS, ISRM/12(58)/2020, 1353,33/14/2023/RD/BMS)
- Saint Joseph's University
- W W Smith Charitable Trust (24\u2013007)
This publication has 75 references indexed in Scilit:
- Discovery of 3-(2-aminobenzo[d]thiazol-5-yl) benzamide derivatives as potent anticancer agents via ROR1 inhibitionBioorganic & Medicinal Chemistry, 2024
- Role of the Ror family receptors in Wnt5a signalingIn Vitro Cellular & Developmental Biology - Animal, 2024
- Design, synthesis, and biological evaluation of 6-(imidazo[1,2-a] pyridin-6-yl) quinazolin-4(3H)-one derivatives as potent anticancer agents by dual targeting Aurora kinase and ROR1Bioorganic Chemistry, 2023
- Carboxamide appended quinoline moieties as potential anti-proliferative agents, apoptotic inducers and Pim-1 kinase inhibitorsMedicinal Chemistry Research, 2021
- A ROR1 small molecule inhibitor (KAN0441571C) induced significant apoptosis of ibrutinib‐resistant ROR1+ CLL cellseJHaem, 2021
- Thymoquinone inhibits the proliferation and invasion of esophageal cancer cells by disrupting the AKT/GSK‐3β/Wnt signaling pathway via PTEN upregulationPhytotherapy Research, 2020
- The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human CancersThe American Journal of Pathology, 2012
- Clinical and biomarker predictors of side effects from tamoxifenBreast Cancer Research and Treatment, 2011
- Development of Herceptin resistance in breast cancer cellsCytometry Part A, 2003
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984